IgE CH3 peptide vaccine
AssigneePfizer Vaccines, LCC
InventorsAlan Daniel Brown, Brian Robert Champion, Clare Christy, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
Life of this patent
Estimating the term…
Abstract
The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Claims17
An antigenic IgE peptide consisting of the amino acid sequence of SEQ ID NO:312.
Dependencies are inferred from the claim text.